Press/Media
- 1 - 25 out of 1,168 results
Search results
-
What’s the Damage With Long COVID? Advanced Imaging Reveals Clues
27/05/25
1 item of Media coverage
Press/Media
-
Weekly: Tourmaline Bio (TRML: $15.32) slides 7.5%, 2 weeks' volume in a week; -$1.24 [7.5%] Vol Index 1.8 [1 is avg]
24/05/25
1 item of Media coverage
Press/Media
-
Two-bagger Corcept Therapeutics (CORT: $78.69) climbs 4.8%; +$3.61 [4.8%]
24/05/25
1 item of Media coverage
Press/Media
-
Positive Topline Results from the Ongoing Phase 2 TRANQUILITY Trial Evaluating Pacibekitug in Patients with Elevated High Sensitivity C reactive Protein and Chronic Kidney Disease
20/05/25 → 21/05/25
3 items of Media coverage
Press/Media
-
Tourmaline Bio to Presented Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
20/05/25
1 item of Media coverage
Press/Media
-
Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
20/05/25
2 items of Media coverage
Press/Media
-
To Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
20/05/25
1 item of Media coverage
Press/Media
-
Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
20/05/25
1 item of Media coverage
Press/Media
-
Tourmaline Bio Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
20/05/25
1 item of Media coverage
Press/Media
-
Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
19/05/25
75 items of Media coverage
Press/Media
-
Two-bagger Corcept Therapeutics (CORT: $75.08) gains 7%; +$4.85 [6.9%]
17/05/25
1 item of Media coverage
Press/Media
-
Israeli PM Netanyahu: ethnic cleansing of Gaza is “inevitable” – War on Gaza Day 585
15/05/25
1 item of Media coverage
Press/Media
-
Mount Sinai Researchers in Semifinals of $101 Million XPRIZE Healthspan, a Competition Seeking Innovative Approaches to Aging Well
Merad, M., Marron, T., Fayad, Z. & Elahi, F.
13/05/25
1 item of Media coverage
Press/Media
-
A breakthrough in regenerating insulin-producing cells for diabetes treatment
García-Ocaña, A., Stanley, S. & Wang, P.
13/05/25
1 item of Media coverage
Press/Media
-
Mount Sinai Researchers In Semifinals Of $101 Million XPRIZE Healthspan, A Competition Seeking Innovative Approaches To Aging Well
Merad, M., Marron, T., Fayad, Z. & Elahi, F.
12/05/25
24 items of Media coverage
Press/Media
-
Weekly: Tourmaline Bio (TRML: $15.10) shares post worst week in five weeks; -$1.20 [7.4%]
10/05/25
1 item of Media coverage
Press/Media
-
HMN 2025: How New gene is linked to extreme circumstances of Fanconi anemia
10/05/25
1 item of Media coverage
Press/Media
-
Weekly: Corcept Therapeutics (CORT: $70.23) drops 3.5% on firm volume; -$2.54 [3.5%]
10/05/25
1 item of Media coverage
Press/Media
-
Long COVID tied to long-term changes in heart and lungs leading to cardiac and pulmonary diseases: Study
Trivieri, M., Putrino, D. & Fayad, Z.
9/05/25
1 item of Media coverage
Press/Media
-
Corcept Therapeutics MCap surges $2.3 billion (43%) in 2025, highest in Medical/Drugs sector
9/05/25
1 item of Media coverage
Press/Media
-
Reports Summarize Opioids Research from Icahn School of Medicine at Mount Sinai (Peripheral Blood Cytokines as Markers of Longitudinal Change in White Matter Microstructure Following Inpatient Treatment for Opioid Use Disorders)
King, S., Cathomas, F., Ceceli, A., Roussos, P., Alia-Klein, N., Goldstein, R. & Russo, S.
8/05/25
1 item of Media coverage
Press/Media